Valacyclovir Clinical Trials
4 recruitingDrug
Phase 32Phase 11Phase 21
Showing 1–4 of 4 trials
Recruiting
Phase 3
Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA)
Non-squamous Non-small Cell Lung Cancer
Candel Therapeutics, Inc.500 enrolled1 locationNCT07660094
Recruiting
Phase 1
Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors
Resectable Brain NeoplasmRecurrent Diffuse Hemispheric Glioma, H3 G34-MutantRecurrent Malignant Brain Neoplasm
University of Michigan Rogel Cancer Center11 enrolled1 locationNCT06914479
Recruiting
Phase 2
Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)
Leukemia
M.D. Anderson Cancer Center60 enrolled1 locationNCT05536349
Recruiting
Phase 3
Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir
Pregnant womenCMV Infected Fetuses
Assistance Publique - Hôpitaux de Paris46 enrolled1 locationNCT05446571